Ultra-endurance exercise significantly lowers soluble CD40 ligand (sCD40L), a marker for cardiovascular risk, in trained athletes.
The study involved nine athletes who engaged in 17 hours of cycling and jogging, with blood samples taken before, during, and after the exercise.
The findings suggest that the decrease in sCD40L levels during and after ultra-endurance activities may contribute to the cardiovascular benefits associated with regular exercise.